Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose

被引：15
|
作者：
Suarez-Kurtz, Guilherme [1 ]
Perini, Jamila A. [1 ]
Silva-Assuncao, Edimilson [1 ]
Struchiner, Claudio J. [1 ]
机构：
[1] Inst Nacl Canc, Div Farmacol, BR-21230050 Rio De Janeiro, Brazil
来源：
BLOOD | 2009年 / 113卷 / 17期
关键词：
POLYMORPHISMS; REQUIREMENTS;
D O I：
10.1182/blood-2009-01-200600
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4125 / 4126
页数：2
相关论文
共 50 条
  • [1] Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy
    Li, Chun
    Schwarz, Ute I.
    Ritchie, Marylyn D.
    Roden, Dan M.
    Stein, C. Michael
    Kurnik, Daniel
    BLOOD, 2009, 113 (17) : 3925 - 3930
  • [2] Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
    Haug K.B.F.
    Sharikabad M.N.
    Kringen M.K.
    Narum S.
    Sjaatil S.T.
    Johansen P.W.
    Kierulf P.
    Seljeflot I.
    Arnesen H.
    Brørs O.
    Thrombosis Journal, 6 (1)
  • [3] RELATIVE CONTRIBUTION OF CYP2C9 AND VKORC1 GENOTYPES AND EARLY INR RESPONSE TO THE PREDICTION OF WARFARIN SENSITIVITY DURING INITIATION OF THERAPY.
    Li, C.
    Schwarz, U. I.
    Ritchie, M. D.
    Roden, D. M.
    Stein, C. M.
    Kurnik, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S73 - S73
  • [4] THE IMPACT OF CYP2C9 AND VKORC1 VARIANTS ON STABLE WARFARIN DOSE IN THE PEDIATRIC POPULATION
    Vear, Susan
    Ayers, Dan
    Stein, C. Michael
    Ho, Richard
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S34 - S35
  • [5] Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 -: Rationale and perspectives
    Yin, Tong
    Miyata, Toshiyuki
    THROMBOSIS RESEARCH, 2007, 120 (01) : 1 - 10
  • [6] Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations
    Gan, Gin Gin
    Phipps, Maude E.
    Lee, Michael M. T.
    Lu, Liang S.
    Subramaniam, Rajallectchumy Y.
    Bee, Ping C.
    Chang, Sean H.
    ANNALS OF HEMATOLOGY, 2011, 90 (06) : 635 - 641
  • [7] Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations
    Gin Gin Gan
    Maude E. Phipps
    Michael M. T. Lee
    Liang S. Lu
    Rajallectchumy Y. Subramaniam
    Ping C. Bee
    Sean H. Chang
    Annals of Hematology, 2011, 90 : 635 - 641
  • [8] The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population
    Vear, Susan I.
    Ayers, Gregory D.
    Van Driest, Sara L.
    Sidonio, Robert F.
    Stein, Charles Michael
    Ho, Richard H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 832 - 835
  • [9] Warfarin sensitivity and CYP2C9 and VKORC1 genes
    Bukaveckas, Bonny Lewis
    INFLAMMATION RESEARCH, 2007, 56 : S223 - S224
  • [10] Genotype of the VKORC1 and CYP2C9 genes in the individual response to warfarin
    Esperon, Patricia
    Raggio, Victor
    Goyeneche, Lucia
    Lorenzo, Mariana
    Taub, Irene
    Stoll, Mario
    REVISTA MEDICA DEL URUGUAY, 2008, 24 (04): : 266 - 276
12345